The New York Times - Addiction Specialists Wary of New Painkiller - Barry Meier

 – November 15, 2013  –– 

A new issue is being raised about the drug Zohydro. The drug will be manufactured by the same company, Alkermes, which makes a popular medication called Vivitrol, used to treat patients addicted to painkillers or alcohol. In addition, the company provides financial support to a leading professional group that represents substance abuse experts, the American Society of Addiction Medicine. For some critics, the company's multiple roles in the world of painkillers is troubling. Stuart Gitlow, Associate Clinical Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai, and the current President of the American Society of Addiction Medicine, said he had been unaware until now of Alkermes's involvement with Zohydro. Dr. Gitlow said that the group would seek more information from Alkermes about the situation and then decide what, if anything, to do next.
-Dr. Stuart Gitlow, Associate Clinical Professor, Psychiatry, Icahn School of Medicine at Mount Sinai
Learn more